Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
Tenaya Therapeutics, a clinical-stage biotechnology company, announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tenaya Therapeutics, a clinical-stage biotechnology company, announced its participation in two upcoming investor conferences. The first event is the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, featuring a fireside chat at 3:30 p.m. ET. The second is the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022, where the company will present at 3:00 p.m. ET. Webcasts of both events will be available on Tenaya's website for 30 days post-conference.
Details
News Market Reaction – TNYA
The recorded move for TNYA in the trading session of this news was +8.51%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced management’s participation in two upcoming investor conferences.
Details of each presentation are as follows:
Morgan Stanley 20th Annual Global Healthcare Conference
Fireside chat
Date: September 13, 2022
Time: 3:30 p.m. ET / 12:30 p.m. PT
H.C. Wainwright 24th Annual Global Investment Conference
Company presentation
Date: September 14, 2022
Time: 3:00 p.m. ET / 12:00 p.m. PT
Webcasts of these events will be available by visiting the Investors section of Tenaya’s website. A replay of each webcast will be available on the Tenaya website for approximately 30 days following each conference.
About Tenaya Therapeutics
Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic cardiovascular disorders, as well as for more prevalent heart conditions, through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.
Investors
Michelle Corral
Tenaya Therapeutics
IR@tenayathera.com
Media
Wendy Ryan
Ten Bridge Communications
wendy@tenbridgecommunications.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.